Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced preliminary, unaudited select ...
In January 2026, 10x Genomics, Inc. reported preliminary 2025 results showing about US$166.0 million in fourth-quarter ...
StockStory.org on MSN
3 hyped up stocks that concern us
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such ...
Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced a collaboration with Dana-Farber ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-first-quarter-2025-financial-results-302450468.html SOURCE ...
The partners are launching ImmuneScape, a multiomics program using spatial and single-cell sequencing to study immune drivers ...
CareDx Inc. has entered a strategic collaboration with 10x Genomics to establish ImmuneScape, a multiomics research ...
A team of 10x Genomics (TXG) scientists conducted a comprehensive analysis of human breast tumor microenvironments using all three of its industry-leading platforms PLEASANTON, Calif., Dec. 19, 2023 ...
10x Genomics made its first acquisition Aug. 28, with the purchase of Epinomics, a startup developing technologies for epigenetics research. Epigenetics is the study of changes in an organism’s DNA ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-second-quarter-2025-financial-results-302524722.html SOURCE ...
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-reports-third-quarter-2025-financial-results-302607636.html SOURCE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback